MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover

investors.com/news/technology/biotech-stock-moonlake-immunotherapeutics-takeover-merck/?src=A00220

Biotech stock MoonLake Immunotherapeutics (MLTX) rocketed Tuesday on a report Merck (MRK) offered to buy it for "more than $3 billion."
It's unlikely a deal would take place before September when MoonLake is expected to unveil final-phase test data for its drug, sonelokimab or SLK, in…

This story appeared on investors.com, 2025-06-03 13:27:21.
The Entire Business World on a Single Page. Free to Use →